• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . SARS-CoV-2 infection prior to vaccination amplifies Fc-mediated humoral profiles in an age-dependent manner

tetano

Editor, Senior Moderator
Cell Rep


. 2024 Aug 29;43(9):114684.
doi: 10.1016/j.celrep.2024.114684. Online ahead of print. SARS-CoV-2 infection prior to vaccination amplifies Fc-mediated humoral profiles in an age-dependent manner

Wonyeong Jung[SUP] 1 [/SUP], Arturo Abdelnour[SUP] 2 [/SUP], Paulina Kaplonek[SUP] 3 [/SUP], Rolando Herrero[SUP] 4 [/SUP], Jessica Shih-Lu Lee[SUP] 3 [/SUP], Domenic R Barbati[SUP] 3 [/SUP], Taras M Chicz[SUP] 3 [/SUP], Kate S Levine[SUP] 3 [/SUP], Romain Clement Fantin[SUP] 4 [/SUP]; RESPIRA study group[SUP] 4 [/SUP]; Viviana Loria[SUP] 4 [/SUP], Carolina Porras[SUP] 4 [/SUP], Douglas A Lauffenburger[SUP] 5 [/SUP], Mitchell H Gail[SUP] 6 [/SUP], Amada Aparicio[SUP] 2 [/SUP], Allan Hildesheim[SUP] 4 [/SUP], Galit Alter[SUP] 7 [/SUP], Ryan P McNamara[SUP] 8 [/SUP]



Affiliations
Abstract

Immunity acquired by vaccination following infection, termed hybrid immunity, has been shown to confer enhanced protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by enhancing the breadth and potency of immune responses. Here, we assess Fc-mediated humoral profiles in hybrid immunity and their association with age and vaccine type. Participants are divided into three groups: infection only, vaccination only, and vaccination following infection (i.e., hybrid immunity). Using systems serology, we profile humoral immune responses against spikes and subdomains of SARS-CoV-2 variants. We find that hybrid immunity is characterized by superior Fc receptor binding and natural killer (NK) cell-, neutrophil-, and complement-activating antibodies, which is higher than what can be expected from the sum of the vaccination and infection. These differences between hybrid immunity and vaccine-induced immunity are more pronounced in aged adults, especially for immunoglobulin (Ig)G1, IgG2, and Fcγ receptor-binding antibodies. Our findings suggest that vaccination strategies that aim to mimic hybrid immunity should consider age as an important modifier.

Keywords: CP: Immunology; antibodies; effector functions; hybrid immunity; infection; natural killer cells; vaccination.

 
Back
Top Bottom